1Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer binding protein NF-κB by a posttranslational mechanism[J]. Cell, 1986, 47(6): 921-928.
2Ghosh S, May MJ, Kopp EB. NF- kappa B and rel proteins: Evalutlonadly conserved raediators of immune responses[J ]. Annu Rev Immunol, 1998, 16(3): 225-260.
3Shishodia S, Majumdar S, Banerjee S, et al. Ursollc acid intuits nuclear factor κB activation induced by carcinogenic agents though suppression of IκB alpha kinase and p65 phosphorylation: correhtion with down 2 regulation of cyclooxygenase, matrix metalloproteinase 9, and cydinDl[J]. Cancer Res, 2003, 63 (15): 4 375-4 383.
4Schmitz MI, Bacher S, Kracht M, et al. I -κB independent control of NF - κB activity by modulatory phosphoryhtions [ J ]. Trends Biochem Sci, 2001, 26(3) : 186 - 190.
5Ramakrishnan P, Wang W, WaUach D. Receptor specific signaling for both the alternative and the canonical NF- kappa B activation pathways by NF- kappa B induced kinase[J ]. Immunity, 2004, 21(4): 477-489.
6Shenkar R, Schwartz MD, Terada IS, et al. Hemorrhage activates NF- kappa B in murine lung mononuchar ceils in vivo. Am J Physiol, 1996, 270 (5p art1): 729-735.
7Ethridge RT, Hashimoto K, Chung DH, et al. Selective inhibition of NF-κB attenuates the severity of cerulean-induced acute pencreatitis[J]. Am Coll Surg, 2002, 195(4): 495 -505.
8Yuehong Y, Xiaoli J, Yimin C, et al. Role and significance of nuclear factor κB activity in systemic inflammatory response syndrome[J]. Chin J Posrgrad Med, 2006, 29(4): 23-25.
9Kyoungho S, Sun YK, Hocheol K. Regulation of IL- 18 production by IFN- 7 and PGE2 in mouse microglial cells: involvement of NF-κB pathway in the regulatory processes[J ]. Immunology Letters, 77(2001): 79 - 85.
10Chen G, Shi J, Qi M, et al. Glutamine decreases intestinal nuclear factor kappa B activity and pro- inflammatory cytokine expression after traumatic brain injury in rats[J]. Inflamm Res, 2008, 57(2) : 57 - 64.
6Xue M,Del-Bigio MR.Intracortical hemorrhage injury in rat:relationship between blood fractions and brain cell death[J].Stroke,2000,31:1721.
7Yang GY,Betz AL,Chenerert TL,et al.Experimental intracerebral hemorrhage:relationship between brain edema,blood flow,and blood-brain barrier permeability in rat[J].Neurosurgery,1994,81:93.
8Xue M,Del-Bigio MR.Intracerebral injection of autologous whole blood in rat:time course of inflammation and cell death[J].Neuroscience Letters,2000,283:230.
9Chen FE,Huang DB,Chen YQ,et al.Crystal structure of p50/p65heterodimer of transcription factor NF-κB bound to DNA[J].Nature,1998,391:410.
10Williams AJ,Hale SL,Dave JR,et al.Delayed treatment with MLN 519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via anti-inflammatory mechanisms involving nuclear factor-kappaB activation,gliosis,and leukocyte infiltration[J].J Cereb Blood Flow Metab,2003,23:75.
3Semenza G L, Perspectives on oxygen sensing. Cell, 1999, 98 (3) : 281-284.
4Depping R, Steinhoff A, Schindler S G, et al. Nuclear translocation of hypoxia-inducible factors (HIFs) : Involvement of the classical importin α/β pathway. Biochimica et Biophysica Acta. 2007, 11(4): 394-404.
5Semenza G L. HIF-1 and mechanisms of hypoxia sensing, cell regulation, 2001, 13(2) : 167-171.
6Bell E L, Emerling B M, Chandel N S. Mitochondrial regulation of oxygen sensing. Mitochondrion, 2005, 6 (5) : 322-332.
7Liu Y V, Back J H, Zhang H, et al. RACKI competes with HsP90 for binding to HIF-1 alpha and is required for 02- independent and HSP90 inhibltor-induced degradation of HIE-1 alpha. Molecular Cell, 2007, 25(2): 207-217.
8Senger D R, Galli S J, Dvorak A M, et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid, Science, 1983, 219(4587): 983-985.
9Ferrara N, Henzel W J. Pituitary follicular ceils secrete a novel heparin binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun, 1989, 161 (2) : 851-858.
10Ng Y S, Krilleke D, Shima D T. VEGF function in vascular pathogenesis. Experimental Cell Research. 2006, 312(5) : 527- 537.
